Moore David Scott (CIK 2088466) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-15). Recent activity: Buy CRVS (21,700 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Corvus Pharmaceuticals, Inc. (CRVS) | Director | Buy | 21,700 | $250,201 |
来源：SEC Form 4 申报文件 · 截至 2026-06-15